Abstract--Many plant drugs are studied for effecting in the treatment of Diabetes mellitus. In the present study ethanolic extract of herb of Catharanthus pusillus was evaluated for hypoglycemic effect in Streptozotocin induced diabetic rats using both 18 hour fasted rat model and oral glucose tolerance test. A comparison was made between the actions of ethanolic extract Catharanthus Pusillus and known anti diabetic drug Glibenclamide (5 mg/kg, p.o). The ethanolic extract of Catharanthus Pusillus was administered at different doses to normal and diabetic rats. The ethanolic extract at 500 mg/kg body weight dose level exhibited significant hypoglycemic activity (P < 0.01 and P < 0.001). Phytochemical screening of aqueous, methanolic, ethanolic and chloroform extract revealed the presence of alkaloids, saponins and carbohydrates. It is concluded that ethanolic extract of herb of Catharanthus Pusillus posses anti diabetic activity.
Introduction: Hyperlipidemia is a medical condition indicated by an increase in one or more plasma lipids, such as triglycerides, cholesterol, cholesterol esters, phospholipids, and/or plasma lipoproteins, such as very low-density lipoprotein and low-density lipoprotein, as well as decreased levels of high-density lipoprotein. This increase in plasma lipids is one of the most important risk factors for cardiovascular disease. In the meanwhile, statins and fibrates remain the most common anti-hyperlipidemic drugs for treating high plasma cholesterol and triglycerides.
Conclusion: Hence this review focused to study of hyperlipidemia. This review is useful to research work in hyperlididemia.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.